Gout has traditionally been associated with older adults. However, new research published in October 2026 suggests that the disease is becoming increasingly common among younger populations in North America.

A scientific review titled Gout in North America, published in the journal Gout, Urate and Crystal Deposition Disease, examined trends in gout prevalence, risk factors, and treatment across the United States and Canada.

The findings highlight a growing public health concern: gout is affecting more people, appearing at younger ages, and frequently going undertreated.

1. Early-Onset Gout Has Increased 63%

The review reports that early-onset gout increased by approximately 63% over three decades.

The estimated incidence of early-onset gout was:

• 115 cases per 100,000 people in high-income North America.

• 44 cases per 100,000 people globally.

This suggests that younger people in North America face a substantially greater burden of gout than the global average.

2. Nearly One in Three American Adolescents Had Elevated Uric Acid

Elevated uric acid, also called hyperuricemia, is an important risk factor for developing gout.

However, elevated uric acid does not automatically mean someone has gout. Many people have high uric acid levels without developing symptoms.

The findings nevertheless raise questions about metabolic health and future gout risk among younger Americans.

3. Gout Affects Millions of American Adults

Gout is the most common form of inflammatory arthritis in the United States and Canada.

The review also projects that high-income North America will have the world's highest age-standardized gout prevalence by 2050.

These findings suggest that the burden of gout may continue to increase in coming decades.

4. Excess Body Weight Is a Major Contributor

The research identifies high body mass index (BMI) as the leading contributor to gout-related disability among younger populations.

Excess body weight is associated with metabolic changes that can increase uric acid production and reduce the body's ability to eliminate it.

Importantly, gout is not simply a dietary disease. Genetics, kidney function, metabolic health, and other factors also influence uric acid levels.

5. Only One in Three Gout Patients Were Receiving Urate-Lowering Therapy

Despite the availability of effective medications, long-term gout treatment remains inconsistent.

Urate-lowering medications, such as allopurinol and febuxostat, are designed to reduce uric acid levels over time.

The review highlights an important treatment gap: many patients are not receiving or consistently using therapies that can prevent future crystal accumulation and gout attacks.

6. Long-Term Medication Adherence Remains a Challenge

Research also suggests that more than half of patients discontinue urate-lowering treatment within one year.

One challenge in gout management is that patients may feel completely healthy between attacks.

However, the absence of pain does not necessarily mean uric acid levels have returned to a healthy range.

Urate crystals can persist between flares, allowing the disease to progress without obvious symptoms.

7. Consistent Treatment Is Associated With Better Uric Acid Control

An Ontario study cited in the review found that patients who remained adherent to urate-lowering therapy had approximately five times the odds of reaching their serum urate treatment goal.

For most patients receiving urate-lowering treatment, the recommended target is:

Maintaining uric acid below the recommended target helps existing urate crystals dissolve over time and reduces the likelihood of future gout attacks.

8. Kidney Function Plays a Central Role in Uric Acid Regulation

The kidneys are responsible for eliminating most of the uric acid that leaves the body, while the gastrointestinal tract handles a smaller portion.

When the body produces more uric acid than it can eliminate, uric acid levels may rise.

Over time, elevated uric acid can lead to monosodium urate crystal formation in joints and surrounding tissues.

This is why understanding kidney function, uric acid levels, and overall metabolic health is important in long-term gout management.

The Bigger Picture

The latest research highlights three important issues:

1. Gout is no longer primarily an older person's disease. Rates among younger populations have increased substantially.

2. Elevated uric acid can exist without symptoms. The absence of a gout attack does not necessarily mean the underlying problem has resolved.

3. Long-term management matters. Maintaining uric acid at appropriate levels is essential for reducing future attacks and preventing complications.

As gout continues to affect more North Americans, education, early diagnosis, and consistent treatment will become increasingly important.

Scientific Source

Sudireddy D, Shaikh M, Chandratre P, Choy G, Neogi T, Kwok TSH. Gout in North America. Gout, Urate and Crystal Deposition Disease. 2026;4(4):19. Published October 2, 2026.

Read the original peer-reviewed scientific review

Note: This article summarizes findings from a scientific review. Several statistics are drawn from older studies included in that review, rather than from new patient data collected in 2026.